Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Arch Bronconeumol
    October 2024
  1. GUIXING X, Yilin L, Huaying F, Fanrong L, et al
    Effect of the Antibody-mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00406.
    >> Share

  2. PADILLA-GALO A, Rubio-Moreno M, Valencia-Azcona B
    Asthma-COPD Overlap - A Gateway to Biological Treatment.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00409.
    >> Share

  3. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G
    Reply to Letter: The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Oct 9:S0300-2896(24)00377.
    >> Share

  4. SCHILFARTH P, Maurac A, Macey J, Decloedt C, et al
    Sleep Quality in Patients Receiving Long-term NIV: A Prospective Cohort Study.
    Arch Bronconeumol. 2024;60:652-655.
    >> Share

  5. PINERO-GUTIERREZ P, Villar-Alvarez F, Asensio-Mathews P, Gonzalez-Peinado D, et al
    Organizing Pneumonia Secondary to ASIA Syndrome.
    Arch Bronconeumol. 2024;60:658-659.
    >> Share

  6. JO YS, Rhee CK, Kim SH, Lee H, et al
    Spirometric Transition of at Risk Individuals and Risks for Progression to Chronic Obstructive Pulmonary Disease in General Population.
    Arch Bronconeumol. 2024;60:634-642.
    >> Share

  7. KERGET B, Cinar I, Akdag BN, Yesilyurt M, et al
    New Indicators of Exercise Capacity and Respiratory Function in COPD Patients: The Role of Gastrocnemius Muscle Oxygenation and Elastography Levels.
    Arch Bronconeumol. 2024;60:643-645.
    >> Share

  8. KHO SS, Ing SK, Tie ST
    The Effect of Bronchoscopic Lung Volume Reduction on Hemidiaphragm Excursion.
    Arch Bronconeumol. 2024;60:668-669.
    >> Share

    September 2024
  9. PLAZA V, Garcia G, Perez de Llano L, Quirce S, et al
    Initiating Biological Treatment of Asthma: When is the Right Time?
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00364.
    >> Share

  10. TIOTIU CEPUC A, Steiropoulos P, Novakova S, Nedeva D, et al
    Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00367.
    >> Share

  11. TRAVERSI L, Garriga-Grimau L, Moreno-Galdo A, Polverino E, et al
    The In-between: Time to Talk About Bronchiectasis in Adolescents and Their Transition to Adult Care.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00359.
    >> Share

  12. BARREIRO E, Gea J
    Muscle Fatigability of Patients With Severe COPD and Chronic Respiratory Failure: The Contribution of Respiratory Factors.
    Arch Bronconeumol. 2024;60:543-544.
    >> Share

  13. MALLAH N, Urbieta AD, Rivero-Calle I, Gonzalez-Barcala FJ, et al
    New Vaccines for Chronic Respiratory Patients.
    Arch Bronconeumol. 2024;60:565-575.
    >> Share

  14. VILLENEUVE T, Guilleminault L, Guibert N
    Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?
    Arch Bronconeumol. 2024;60:600-601.
    >> Share

    August 2024
  15. ALOBID I, Bernal-Sprekelsen M, Mullol J
    The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Aug 31:S0300-2896(24)00317.
    >> Share

  16. JACOME C, Jacome M, Correia S, Flores I, et al
    Effectiveness, Adherence and Safety of Home High Flow Nasal Cannula in Chronic Respiratory Disease and Respiratory Insufficiency: A Systematic Review.
    Arch Bronconeumol. 2024;60:490-502.
    >> Share

    July 2024
  17. GIL-MARTINEZ M, Rodrigo-Munoz JM, Antonio Canas J, Sastre J, et al
    Sputum Proteome Reveals Differences Between Eosinophilic and Non-eosinophilic Asthma Phenotypes.
    Arch Bronconeumol. 2024 Jul 20:S0300-2896(24)00273.
    >> Share

  18. WU X, Deng Z, Wu F, Zheng Y, et al
    Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China.
    Arch Bronconeumol. 2024;60:402-409.
    >> Share

  19. AGUSTI A, Lopez-Campos JL, Miravitlles M, Soler-Cataluna JJ, et al
    Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial.
    Arch Bronconeumol. 2024;60:417-422.
    >> Share

  20. PANERONI M, Cavicchia A, Beatrice S, Bertacchini L, et al
    The Influence of Lung Function and Respiratory Muscle Strength on Quadriceps Muscle Fatigability in COPD Patients Under Long-term Oxygen Therapy.
    Arch Bronconeumol. 2024;60:410-416.
    >> Share

    June 2024
  21. COSIO BG, Shafiek H, Torrego A
    Bronchoscopy in Severe Asthmatics: Is it a Safe Procedure?
    Arch Bronconeumol. 2024 Jun 18:S0300-2896(24)00224.
    >> Share

  22. MA D, Munoz X, Ojanguren I, Romero-Mesones C, et al
    Increased TGFbeta1, VEGF and IFN-gamma in the Sputum of Severe Asthma Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Jun 7:S0300-2896(24)00221.
    >> Share

  23. DE MIGUEL-DIEZ J, Gomez Doblas JJ
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Response to Additional Considerations.
    Arch Bronconeumol. 2024;60:392-393.
    >> Share

  24. GOLPE R, Figueira-Goncalves JM
    Comment on "Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease".
    Arch Bronconeumol. 2024;60:391.
    >> Share

  25. FERNANDEZ-VILLAR A, Cimas Hernando JE, Figueira Goncalves JM, De Miguel Diez J, et al
    Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities.
    Arch Bronconeumol. 2024;60:327-329.
    >> Share

    May 2024
  26. GONZALEZ J, Seijo LM, de-Torres JP, Benitez ID, et al
    Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00170.
    >> Share

  27. GARRIGA-GRIMAU L, Sanz-Santiago V, Moreno-Galdo A
    Implementation of the Spanish Paediatric Bronchiectasis Registry (Child-BEAR-es Registry).
    Arch Bronconeumol. 2024 May 6:S0300-2896(24)00143.
    >> Share

  28. FORCADA BARREDA C, Fuentes Gago MG, Gomez Hernandez MT
    Subconjunctival Emphysema After Videothoracoscopic Segmentectomy.
    Arch Bronconeumol. 2024 May 4:S0300-2896(24)00138.
    >> Share

  29. BALLESTEROS-REVIRIEGO G, Arbillaga-Etxarri A, Marti JD
    Inspiratory Muscle Training: Back to Basics Must be the First Step?
    Arch Bronconeumol. 2024;60:267-268.
    >> Share

  30. PAPI A, Alfano F, Bigoni T, Mancini L, et al
    N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
    Arch Bronconeumol. 2024;60:269-278.
    >> Share

  31. CUENCA PERIS S, Martinez Tomas R, Briones Gomez A, Cases Viedma E, et al
    What to Do When Endobronchial Volume Reduction Treatment Fails.
    Arch Bronconeumol. 2024;60:319-320.
    >> Share

    April 2024
  32. CAKIR E, Ibis E, Yuzuak E
    Probable Invasive Aspergillosis Causing Massive Subcutaneous Emphysema by Rupturing the Pleura and Forming a Bronchopleural Fistula.
    Arch Bronconeumol. 2024 Apr 30:S0300-2896(24)00131.
    >> Share

  33. MASELLI DJ, Diaz AA
    Mortality Risk in Bronchiectasis.
    Arch Bronconeumol. 2024 Apr 24:S0300-2896(24)00114.
    >> Share

  34. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G, Blanco-Aparicio M, et al
    Spanish Consensus on Remission in Asthma (REMAS).
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00109.
    >> Share

  35. PAN CX, He ZF, Lin SZ, Yue JQ, et al
    Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association.
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00110.
    >> Share

  36. MAKRINIOTI H, Zhu Z, Saglani S, Camargo CA, et al
    Infant Bronchiolitis Endotypes and the Risk of Developing Childhood Asthma: Lessons From Cohort Studies.
    Arch Bronconeumol. 2024;60:215-225.
    >> Share

  37. DE MIGUEL-DIEZ J, Nunez Villota J, Santos Perez S, Manito Lorite N, et al
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
    Arch Bronconeumol. 2024;60:226-237.
    >> Share

    March 2024
  38. GAO YH, Zhu YN, Bai JW, Liang S, et al
    Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
    >> Share

  39. CHANG AB, Dharmage SC, Marchant JM, McCallum GB, et al
    Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation.
    Arch Bronconeumol. 2024 Mar 10:S0300-2896(24)00062.
    >> Share

  40. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
    Effect of Comorbidities and Gender Differences in Survival in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 2:S0300-2896(24)00055.
    >> Share

  41. VITACCA M, Malovini A, Paneroni M, Spanevello A, et al
    Predicting Response to In-Hospital Pulmonary Rehabilitation in Individuals Recovering From Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2024;60:153-160.
    >> Share

    February 2024
  42. FAIZ A, Wiersma VR, Salzbrunn JB, Brandsma CA, et al
    COPD Patients Display Increased Peripheral Blood Somatic Mutations Which Associate With the Prevalence of Co-morbidities.
    Arch Bronconeumol. 2024;60:119-121.
    >> Share

  43. GIRON MATUTE WI, Ji Z, de Miguel Diez J
    Clinical Trials in COPD: Future Challenges.
    Arch Bronconeumol. 2024;60:75-76.
    >> Share

    January 2024
  44. PALONES E, Garcia-Rivero JL, Cisneros C, Almonacid-Sanchez C, et al
    Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma.
    Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00003.
    >> Share

  45. MAKRINIOTI H, Homil K, Hurme P, Erkkola R, et al
    Peripheral Blood MxA Levels During a First Acute Wheezing Episode and the Link to Childhood Asthma.
    Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00001.
    >> Share

  46. BEASLEY R, Ferreira DS, Papi A
    As-needed Dual Inhaled Corticosteroid-Formoterol in Mild Asthma: Scientific Evidence.
    Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00004.
    >> Share

  47. LI W, Dong P, Wang W
    Unveiling the Link between Asthma and Cancer Risk: Shedding New Light through Mendelian Randomization.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00418.
    >> Share

  48. LUNA-PARDO C, Cruz-Chamorro DA, Martinez-Tomas R, Briones-Gomez A, et al
    Endoscopic Lung Volume Reduction With Vapor Ablation in Patients With Severe Emphysema.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00419.
    >> Share

  49. DE-TORRES JP, Alcaide AB, Campo A, Zulueta JJ, et al
    Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00417.
    >> Share

  50. LOEB E, Zock JP, Miravitlles M, Rodriguez E, et al
    Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population.
    Arch Bronconeumol. 2024;60:16-22.
    >> Share

  51. FIGUEIRA-GONCALVES JM, de Miguel-Diez J
    Initial Treatment in COPD Patients. Do We Take into Account the Severity of the Exacerbation?
    Arch Bronconeumol. 2024;60:65-66.
    >> Share

  52. RIESCO MIRANDA JA, Calle Rubio M, Diaz Perez D, Lopez-Campos JL, et al
    Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review.
    Arch Bronconeumol. 2024;60:55-58.
    >> Share

  53. DE-TORRES JP, Casanova C, Marin JM, Cabrera C, et al
    Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience.
    Arch Bronconeumol. 2024;60:10-15.
    >> Share

  54. DE MIGUEL-DIEZ J, Figueira-Goncalves JM, Trillo-Calvo E, Cimas-Hernando JE, et al
    Referral Criteria for Chronic Obstructive Pulmonary Disease: A Proposal of Continuity of Care.
    Arch Bronconeumol. 2024;60:7-9.
    >> Share

    December 2023
  55. ORDONEZ LOZANO PA, Ruiz JM, Rey Gutama H
    Large Cystic Bronchiectasis: A Differential Diagnosis.
    Arch Bronconeumol. 2023 Dec 18:S0300-2896(23)00408.
    >> Share

  56. MORENA D, Lumbreras S, Rodriguez JM, Campos C, et al
    Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection.
    Arch Bronconeumol. 2023;59:797-804.
    >> Share

  57. BUSTAMANTE-GUEVARA GV, Iglesias-Serrano I, Camacho Soriano J
    Refractory Inflammatory Plastic Bronchitis in Children and the Use of Mepolizumab as a Treatment.
    Arch Bronconeumol. 2023;59:829-830.
    >> Share

    November 2023
  58. VALVERDE-MONGE M, Sanchez-Carrasco P, Betancor D, Barroso B, et al
    Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients.
    Arch Bronconeumol. 2023 Nov 22:S0300-2896(23)00379.
    >> Share

  59. CALLE RUBIO M, Miravitlles M, Lopez-Campos JL, Alcazar Navarrete B, et al
    Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit.
    Arch Bronconeumol. 2023;59:725-735.
    >> Share

  60. REY-BRANDARIZ J, Perez-Rios M, Ahluwalia JS, Beheshtian K, et al
    Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study.
    Arch Bronconeumol. 2023;59:717-724.
    >> Share

  61. MARTINEZ TOMAS R, Briones-Gomez A, Cases Viedma E
    Bronchoscopy Valves for Lung Volume Reduction: Present and Future.
    Arch Bronconeumol. 2023;59:707-708.
    >> Share

    October 2023
  62. ALMONACID-SANCHEZ C, Garcia-Cosio B, Trisan-Alonso A, Callejas-Gonzalez FJ, et al
    Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population.
    Arch Bronconeumol. 2023 Oct 5:S0300-2896(23)00310.
    >> Share

    September 2023
  63. COHEN D, Osadchy A, Cohen-Hagai K, Jarchowsky Dolberg O, et al
    Bronchiectasis in Subjects With Chronic Lymphocytic Leukemia.
    Arch Bronconeumol. 2023 Sep 29:S0300-2896(23)00308.
    >> Share

  64. DE DIEGO DAMIA A, Martinez Valle AM
    Antialarmins in Severe Asthma.
    Arch Bronconeumol. 2023 Sep 29:S0300-2896(23)00303.
    >> Share

  65. RABOSO MORENO B, Calero Pardo S, Abad Fernandez A
    Bardet-Biedl Syndrome: An Uncommon Cause of Bronchiectasis.
    Arch Bronconeumol. 2023 Sep 9:S0300-2896(23)00281.
    >> Share

  66. AUSIN P, Navarrete-Rouco ME
    Multiple Targets, Multiple Pathways, Multiple Strategies in the Treatment of Asthma.
    Arch Bronconeumol. 2023 Sep 6:S0300-2896(23)00279.
    >> Share

    August 2023
  67. PINOT DE MOIRA A, Taylor-Robinson D
    Social Inequalities in Asthma: The Cold Facts.
    Arch Bronconeumol. 2023 Aug 5:S0300-2896(23)00263.
    >> Share

  68. PILIA MF, Cruz MJ, Ma D, Romero-Mesones C, et al
    The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy.
    Arch Bronconeumol. 2023 Aug 5:S0300-2896(23)00264.
    >> Share

  69. DELORME M, Leotard A, Lebret M, Lefeuvre C, et al
    Effect of Intensity of Home Noninvasive Ventilation in Individuals With Neuromuscular and Chest Wall Disorders: A Systematic Review and Meta-Analysis of Individual Participant Data.
    Arch Bronconeumol. 2023;59:488-496.
    >> Share

    July 2023
  70. MARTINEZ-GARCIA MA, Oscullo G, Gomez-Olivas JD, Olveira C, et al
    Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries.
    Arch Bronconeumol. 2023 Jul 27:S0300-2896(23)00261.
    >> Share

  71. CAZZOLA M, Matera MG, Martinez-Garcia MA
    Dual Broncodilator and Triple Therapy in Bronchiectasis. Clinical Trials are Urgently Needed.
    Arch Bronconeumol. 2023 Jul 22:S0300-2896(23)00228.
    >> Share

  72. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
    Impact of Comorbidities in Clinical Outcomes in Patients Admitted for Exacerbation of Bronchiectasis.
    Arch Bronconeumol. 2023 Jul 22:S0300-2896(23)00234.
    >> Share

  73. DE LA ROSA-CARRILLO D, Maiz-Carro L, Martinez-Garcia MA
    What Have We Learned About Bronchiectasis From RIBRON (Spanish Bronchiectasis Registry)?
    Arch Bronconeumol. 2023 Jul 15:S0300-2896(23)00226.
    >> Share

  74. SALAHUDDIN M, Alavi M, Nasir S
    Invasive Aspergillosis and Pseudomembranous Tracheitis in Uncontrolled Diabetes.
    Arch Bronconeumol. 2023;59:449-450.
    >> Share

  75. BLANCO I, Diego I, Castanon C, Bueno P, et al
    Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:427-434.
    >> Share

  76. FIGUEIRA-GONCALVES JM, Golpe R
    Impact of Oral Antidiabetics Agents in the Prevention of COPD Exacerbations.
    Arch Bronconeumol. 2023;59:412-413.
    >> Share

    June 2023
  77. FIGUEIRA-GONCALVES JM, Hernandez-Perez JM, Cabrera-Lopez C, Wanguemert-Perez AL, et al
    Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease.
    Arch Bronconeumol. 2023;59:403-405.
    >> Share

  78. RODRIGUEZ-SEGADE ALONSO S, Diego Roza C, Marzoa Rivas R, Nieto Codesido I, et al
    Prevalence and Risk Factors for Airflow Limitation in Patients With Acute Coronary Syndrome.
    Arch Bronconeumol. 2023;59:397-400.
    >> Share

  79. LACASSE Y, Maltais F
    When and When Not to Prescribe Home Oxygen in COPD.
    Arch Bronconeumol. 2023;59:350-351.
    >> Share

  80. BETANCOR D, Villalobos-Vilda C, Olaguibel JM, Rodrigo-Munoz JM, et al
    The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort.
    Arch Bronconeumol. 2023 Jun 1:S0300-2896(23)00173.
    >> Share

  81. COSIO BG, Shafiek H, Iglesias A, Mosteiro M, et al
    Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils.
    Arch Bronconeumol. 2023 Jun 1:S0300-2896(23)00172.
    >> Share

    May 2023
  82. GONZALEZ-DE PAZ L, Valdesoiro-Navarrete L, Roma J, Blat-Guimera E, et al
    Prevalence and Impact of Asthma and Allergy on Daily Life, Health Outcomes and Use of Healthcare Services in Children: A Population-Based Study.
    Arch Bronconeumol. 2023 May 24:S0300-2896(23)00163.
    >> Share

  83. MARTINEZ RIVERA C, Serra Mitja P, Andreo Garcia F, Crespo-Lessmann A, et al
    Factors Associated With Large Airway Collapse in Severe Asthma.
    Arch Bronconeumol. 2023 May 24:S0300-2896(23)00164.
    >> Share

  84. MARTINEZ-MORAGON E
    Cost-Effectiveness of Biologic Therapies in Asthma in Spain.
    Arch Bronconeumol. 2023 May 23:S0300-2896(23)00165.
    >> Share

  85. CALLE RUBIO M, Lopez-Campos JL, Miravitlles M, Soler Cataluna JJ, et al
    Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit.
    Arch Bronconeumol. 2023;59:295-304.
    >> Share

  86. GEA J, Enriquez-Rodriguez CJ, Pascual-Guardia S
    Metabolomics in COPD.
    Arch Bronconeumol. 2023;59:311-321.
    >> Share

  87. POLVERINO F, Celli B
    Challenges in the Pharmacotherapy of COPD Subtypes.
    Arch Bronconeumol. 2023;59:284-287.
    >> Share

    April 2023
  88. JIMENEZ-GOMEZ M, Diaz Campos RM, Diab Caceres L
    Cystic Fibrosis-Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma.
    Arch Bronconeumol. 2023 Apr 20:S0300-2896(23)00126.
    >> Share

  89. GALAN-NEGRILLO M, Garcia-Pachon E
    Reduction in Hospital Admissions for Asthma and COPD During the First Year of COVID-19 Pandemic in Spain.
    Arch Bronconeumol. 2023 Apr 20:S0300-2896(23)00125.
    >> Share

  90. AGUSTI A, Celli BR, Criner GJ, Halpin D, et al
    Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
    Arch Bronconeumol. 2023;59:232-248.
    >> Share

  91. GONZALEZ J, de Batlle J, Benitez ID, Torres G, et al
    Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
    Arch Bronconeumol. 2023;59:205-215.
    >> Share

  92. MARQUEZ CABALLERO J, Cordero Matia ME
    Epidemiology of Acute Bronchiolitis in a Third-level Hospital During the COVID-19 Pandemic.
    Arch Bronconeumol. 2023;59:264-266.
    >> Share

    March 2023
  93. PEREZ-DE-LLANO L, Veiga-Teijeiro I, Dacal-Rivas D
    Contribution of the Remission Concept to the Treatment of Asthma.
    Arch Bronconeumol. 2023 Mar 21:S0300-2896(23)00108.
    >> Share

  94. LOBO-REBOLLO MJ, Garcia-Baron C, Villar-Alvarez F
    Acute Hemorrhage into an Emphysematous Bulla.
    Arch Bronconeumol. 2023 Mar 21:S0300-2896(23)00106.
    >> Share

  95. GARCIA CASTILLO E, Alonso Perez T, Pelaez A, Perez Gonzalez P, et al
    Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017.
    Arch Bronconeumol. 2023;59:142-151.
    >> Share

  96. PEREIRA BARROS P, Dos Santos B, Brito U
    Difficult Diagnosis of a Foreign Body Inhalation in a COPD Patient.
    Arch Bronconeumol. 2023;59:172.
    >> Share

  97. MAESTRI R, Vitacca M, Paneroni M, Zampogna E, et al
    Gender and Age as Determinants of Success of Pulmonary Rehabilitation in Individuals With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:174-177.
    >> Share

    February 2023
  98. HERNANDEZ-PEREZ JM, Martin-Gonzalez E, Gonzalez-Carracedo MA
    Alpha-1 Antitrypsin Deficiency and SERPINA1 Variants Could Play a Role in Asthma Exacerbations.
    Arch Bronconeumol. 2023 Feb 28:S0300-2896(23)00038.
    >> Share

  99. ARISMENDI E, Bantula M, Picado C
    Obese Asthma Syndrome: Much Work to Do.
    Arch Bronconeumol. 2023 Feb 25:S0300-2896(23)00040.
    >> Share

  100. ALCARAZ-SERRANO V, Sanz-Fraile H, Bueno-Freire L, Farre R, et al
    Association Between Viscoelastic Characteristics and Sputum Colour in Patients With Bronchiectasis.
    Arch Bronconeumol. 2023 Feb 25:S0300-2896(23)00039.
    >> Share

  101. PASCUAL-GUARDIA S, Amati F, Marin-Corral J, Aliberti S, et al
    Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia.
    Arch Bronconeumol. 2023;59:90-100.
    >> Share

  102. LOPEZ-CAMPOS JL, Caballero Eraso C
    Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: So Far, So Good.
    Arch Bronconeumol. 2023;59:71-72.
    >> Share

  103. LOPEZ-PARDO ME, Candal-Pedreira C, Valdes-Cuadrado L, Represas-Represas C, et al
    Factors Linked to Frequent Attendance in the Out-of-hospital Setting by Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:119-122.
    >> Share

    January 2023
  104. MATABUENA M, Salgado FJ, Nieto-Fontarigo JJ, Alvarez-Puebla MJ, et al
    Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis.
    Arch Bronconeumol. 2023 Jan 18:S0300-2896(23)00012.
    >> Share

  105. ALIBERTI S, Gramegna A, Seia M, Malvestiti F, et al
    Alpha(1)-Antitrypsin Inherited Variants in Patients With Bronchiectasis.
    Arch Bronconeumol. 2023 Jan 18:S0300-2896(23)00009.
    >> Share

  106. LUJAN M
    Home High-Flow Oxygen Therapy Should Be Considered in Patients With COPD and Chronic Respiratory Failure.
    Arch Bronconeumol. 2023;59:5-6.
    >> Share

  107. PALONES E, Curto E, Pelegri A, Arilla M, et al
    Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia.
    Arch Bronconeumol. 2023;59:63-65.
    >> Share

  108. SCICLUNA V, Han M
    COPD in Women: Future Challenges.
    Arch Bronconeumol. 2023;59:3-4.
    >> Share

  109. AMADO DIAGO CA, Figueira Goncalves JM, Golpe R, Esteban C, et al
    Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria.
    Arch Bronconeumol. 2023;59:57-58.
    >> Share

    December 2022
  110. NIGRO M, Simonetta E, Martinez-Garcia MA, Aliberti S, et al
    Biologics in Bronchiectasis: A Future Treatment?
    Arch Bronconeumol. 2022 Dec 23:S0300-2896(22)00671.
    >> Share

  111. ZHAO N, Suissa S, Ernst P
    Beta-agonist Use and Increased Asthma Mortality: Reality or Fiction?
    Arch Bronconeumol. 2022 Dec 23:S0300-2896(22)00669.
    >> Share

  112. PIOCH CO, Connell DW, Shoemark A
    Primary Ciliary Dyskinesia and Bronchiectasis: New Data and Future Challenges.
    Arch Bronconeumol. 2022 Dec 18:S0300-2896(22)00663.
    >> Share

  113. GALERA R, Mergelina C, Casitas R, Martinez-Ceron E, et al
    Increased Blood Eosinophil Count Is Related to Less Daily Physical Activity in Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2022;58:837-839.
    >> Share

  114. LIANG Y, Sun Y
    COPD in China: Current Status and Challenges.
    Arch Bronconeumol. 2022;58:790-791.
    >> Share

    November 2022
  115. CHANG AB, Kantar A, Redding GJ, Hill AT, et al
    Is Bronchiectasis a Reversible Disorder?
    Arch Bronconeumol. 2022 Nov 19:S0300-2896(22)00633.
    >> Share

  116. MADRID CARBAJAL C, Palomo B, Garcia Clemente M
    Radiological Changes After Treatment With Triple Therapy in Cystic Fibrosis. Are Bronchiectasis Irreversible?
    Arch Bronconeumol. 2022 Nov 5:S0300-2896(22)00599.
    >> Share

  117. CALLE RUBIO M, Lopez-Campos JL, Izquierdo Alonso JL, Martinez Pitarch D, et al
    Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group.
    Arch Bronconeumol. 2022;58:776-779.
    >> Share

  118. ROMERO-FALCON MA, Medina-Gallardo JF, Lopez-Campos JL, Maestre Sanchez MV, et al
    Evaluation of the Diagnostic Accuracy of Non-Specific Bronchial Provocation Tests in the Diagnosis of Asthma: A Randomized Cross-Over Study.
    Arch Bronconeumol. 2022 Nov 1. pii: S0300-2896(22)00596.
    >> Share

    October 2022
  119. FIGUEIRA-GONCALVES JM, Golpe R
    Medium- and Long-Term Consequences of SARS-CoV-2 Infection on COPD Patients.
    Arch Bronconeumol. 2022;58:729-730.
    >> Share

  120. MONTEAGUDO M, Nunez A, Barrecheguren M, Miravitlles M, et al
    Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study.
    Arch Bronconeumol. 2022;58:699-707.
    >> Share

  121. MARTIN-ONTIYUELO C, Rodo-Pin A, Echeverria-Esnal D, Admetllo M, et al
    Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial.
    Arch Bronconeumol. 2022;58:689-698.
    >> Share

    September 2022
  122. ALVAREZ-GUTIERREZ FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, et al
    What's New in the 2022 Consensus for Severe Asthma in Adults.
    Arch Bronconeumol. 2022 Sep 28. pii: S0300-2896(22)00575.
    >> Share

  123. DIAB CACERES L, Morales Ruiz R, Villena Garrido V
    Does Bronchiectasis Cause Irreversible Damage?
    Arch Bronconeumol. 2022 Sep 27. pii: S0300-2896(22)00576.
    >> Share

  124. SOLARAT B, Perea L, Faner R, de La Rosa D, et al
    Pathophysiology of Chronic Bronchial Infection in Bronchiectasis.
    Arch Bronconeumol. 2022 Sep 15. pii: S0300-2896(22)00525.
    >> Share

  125. SADATSAFAVI M, Aaron SD, Gershon AS, Puhan M, et al
    The Hidden and Unchecked Judgement Calls When Using Exacerbation History for Managing COPD.
    Arch Bronconeumol. 2022;58:629-631.
    >> Share

  126. GONZALEZ J, Carmona P, Gracia-Lavedan E, Benitez ID, et al
    Cluster Analysis of Home Mechanical Ventilation in COPD Patients: A Picture of the Real World and Its Impact on Mortality.
    Arch Bronconeumol. 2022;58:642-648.
    >> Share

  127. RODRIGO-TROYANO A, Giner J, Perea L, Merino JL, et al
    Predicting Early Hospital Readmissions in COPD Patients Using an Electronic Nose.
    Arch Bronconeumol. 2022;58:663-665.
    >> Share

    August 2022
  128. COSIO BG, Shafiek H, Martinez-Garcia MA
    Is it Time to Readjust the Doses of Inhaled Corticosteroids in COPD?
    Arch Bronconeumol. 2022;58:593-594.
    >> Share

  129. ALCAZAR-NAVARRETE B, Diaz-Lopez JM, Garcia-Flores P, Ortega-Antelo M, et al
    T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2022;58:595-600.
    >> Share

  130. SU KC, Ko HK, Hsiao YH, Chou KT, et al
    Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial.
    Arch Bronconeumol. 2022;58:601-610.
    >> Share

  131. SORIANO JB, Dai X, Ancochea J
    An Euler Proportional Venn Diagram of Obstructive Lung Disease.
    Arch Bronconeumol. 2022;58:627-628.
    >> Share

    July 2022
  132. KUNADHARAJU R, Rudraraju A, Sethi S
    Pseudomonas aeruginosa Colonization and COPD: The Chicken or the Egg?
    Arch Bronconeumol. 2022;58:539-541.
    >> Share

    June 2022
  133. XU JF, Gao YH, Guan WJ
    Advances in Bronchiectasis Registries: The New Chinese Registry.
    Arch Bronconeumol. 2022 Jun 11. pii: S0300-2896(22)00447.
    >> Share

  134. KATSOULIS K, Kipourou M, Quaranta Vitaliano N, Kostikas K, et al
    Predicting Bronchial Hyperresponsiveness in Patients with Asthma: The Role of Impulse Oscillometry.
    Arch Bronconeumol. 2022 Jun 2. pii: S0300-2896(22)00438.
    >> Share

  135. LONG MB, Chalmers JD
    Treating Neutrophilic Inflammation in Airways Diseases.
    Arch Bronconeumol. 2022;58:463-465.
    >> Share

  136. MANISCALCO M, Fuschillo S, Ambrosino P, D'Anna SE, et al
    Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients.
    Arch Bronconeumol. 2022;58:517-519.
    >> Share

  137. LUIS IZQUIERDO J, Casanova C, Celli B, Santos S, et al
    The 7 Cardinal Sins of COPD in Spain.
    Arch Bronconeumol. 2022;58:498-503.
    >> Share

  138. GARCIA-VALERO J, Olloquequi J, Rodriguez E, Martin-Satue M, et al
    Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.
    Arch Bronconeumol. 2022;58:482-489.
    >> Share

  139. MARCOS PJ, Represas Represas C, Ramos C, Cimadevila Alvarez B, et al
    Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis.
    Arch Bronconeumol. 2022;58:474-481.
    >> Share

    May 2022
  140. PASCUAL S, Dorado S, Urrutia I
    Physical Activity and Asthma.
    Arch Bronconeumol. 2022 May 17. pii: S0300-2896(22)00342.
    >> Share

  141. SCIOSCIA G, Alcaraz-Serrano V, Mendez R, Gabarrus A, et al
    Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
    Arch Bronconeumol. 2022 May 13. pii: S0300-2896(22)00336.
    >> Share

  142. MARTINEZ-GONZALEZ C, Garcia JA, Blanco I
    [Translated article] Term Pregnancy in a Patient With Severe Pulmonary Emphysema Associated With Pi*ZZ Alpha-1 Antitrypsin Deficiency.
    Arch Bronconeumol. 2022 May 5. pii: S0300-2896(22)00311.
    >> Share

  143. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    [Translated article] Asthma Also Exists in Older People.
    Arch Bronconeumol. 2022 May 4. pii: S0300-2896(22)00312.
    >> Share

  144. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    [Translated article] Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:T451-T453.
    >> Share

  145. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:412-417.
    >> Share

  146. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    [Translated article] Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:T433.
    >> Share

  147. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    [Translated article] Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:T412-T417.
    >> Share

  148. PEREZ PEREZ JL, Garcia-Manso IG, Garcia Sevila R
    [Translated article] Acute Fibrinous and Organizing Pneumonia Associated With Immunotherapy (Pembrolizumab).
    Arch Bronconeumol. 2022;58:T425-T426.
    >> Share

  149. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    [Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:T386-T387.
    >> Share

  150. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    [Translated article] Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:T454-T456.
    >> Share

  151. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:442-443.
    >> Share

  152. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:433.
    >> Share

  153. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:386-387.
    >> Share

  154. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:T442-T443.
    >> Share

  155. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:454-456.
    >> Share

  156. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:451-453.
    >> Share

    April 2022
  157. NAVAS-BUENO B, Casas-Maldonado F, Padilla-Galo A, Gonzalez-Moya-Mondelo E, et al
    High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study.
    Arch Bronconeumol. 2022 Apr 27. pii: S0300-2896(22)00320.
    >> Share

  158. CHINER-VIVES E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, et al
    Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
    Arch Bronconeumol. 2022;58 Suppl 1:39-50.
    >> Share

  159. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    [Translated article] The ANTES Program in COPD: First Year.
    Arch Bronconeumol. 2022;58:T291-T294.
    >> Share

  160. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    [Translated article] Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria With GOLD 2021?
    Arch Bronconeumol. 2022;58:T364-T366.
    >> Share

  161. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:334-344.
    >> Share

  162. MACHUCA AGUADO J, Sabariego-Arenas I, Idoate MA
    A Pulmonary Inflammatory Chondroid Hamartoma With So-called Placental Transmogrification Feature in a Pleural Location. Pathogenic Considerations About This Unusual Disorder.
    Arch Bronconeumol. 2022;58:363.
    >> Share

  163. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?
    Arch Bronconeumol. 2022;58:364-366.
    >> Share

  164. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:345-351.
    >> Share

  165. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    The ANTES program in COPD: First year.
    Arch Bronconeumol. 2022;58:291-294.
    >> Share

  166. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:T345-T351.
    >> Share

  167. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    [Translated article] Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:T323-T333.
    >> Share

  168. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:323-333.
    >> Share

  169. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:T334-T344.
    >> Share

    March 2022
  170. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    Asthma also exists in older people.
    Arch Bronconeumol. 2022 Mar 11. pii: S0300-2896(22)00183.
    >> Share

    February 2022
  171. MARTINEZ-GONZALEZ C, Adanez Garcia J, Blanco I
    Term pregnancy of a patient with severe pulmonary emphysema associated with (PI*ZZ) alpha-1 antitrypsin.
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00094.
    >> Share

  172. BARALDI F, Alfano F, Contoli M, Papi A, et al
    Small Airway Disease in Asthma: Why is it so Important?
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00093.
    >> Share

  173. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
    Arch Bronconeumol. 2022;58:T150-T158.
    >> Share

  174. CAZZOLA M, Rogliani P, Matera MG
    The Future of Bronchodilators in COPD and Asthma.
    Arch Bronconeumol. 2022;58:107-108.
    >> Share

  175. SOLER-CATALUNA JJ, Pinera P, Trigueros JA, Calle M, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome.
    Arch Bronconeumol. 2022;58:T159-T170.
    >> Share

  176. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
    Arch Bronconeumol. 2022;58:T150-T158.
    >> Share

    January 2022
  177. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
    Arch Bronconeumol. 2022;58:35-51.
    >> Share

    December 2021
  178. MARTINEZ-GARCIA MA, Aksamit TR, Aliberti S
    Bronchiectasis as a Long-Term Consequence of SARS-COVID-19 Pneumonia: Future Studies are Needed.
    Arch Bronconeumol. 2021;57:739-740.
    >> Share

  179. FIGUEIRA GONCALVES JM, Golpe R, Ramallo Y, Garcia Talavera I, et al
    Should pulse oximeter saturations be included in the risk stratification for chronic obstructive pulmonary disease proposed by GesEPOC?
    Arch Bronconeumol. 2021;57:774-776.
    >> Share

  180. CALLE RUBIO M, Rodriguez Hermosa JL, Miravitlles M, Lopez-Campos JL, et al
    Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study.
    Arch Bronconeumol. 2021;57:741-749.
    >> Share

  181. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
    Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
    Arch Bronconeumol. 2021;57:731-732.
    >> Share

    November 2021
  182. OJANGUREN I, Satia I, Usmani OS
    The Role of Viral Infections on Severe Asthma Exacerbations: Present and Future.
    Arch Bronconeumol. 2021 Nov 1. pii: S0300-2896(21)00350.
    >> Share

  183. LOPEZ-ALBA A, Aldao-Arguelles I, de Granda-Orive JI
    Plastic bronchitis and Noonan syndrome.
    Arch Bronconeumol. 2021;57:705.
    >> Share

  184. FERREIRO A, Granados G, Villar A
    Peribronchovascular emphysema. The Macklin effect.
    Arch Bronconeumol. 2021;57:697.
    >> Share

  185. DE-TORRES JP, Wisnivesky JP
    Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
    Arch Bronconeumol. 2021;57:679-680.
    >> Share

  186. MARTINEZ-GARCIA MA
    Bronchiectasis and Eosinophils.
    Arch Bronconeumol. 2021;57:671-672.
    >> Share

    October 2021
  187. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
    Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis.
    Arch Bronconeumol. 2021;57:662-664.
    >> Share

  188. RUANO-RAVINA A, Cameselle-Lago C, Torres-Duran M, Pando-Sandoval A, et al
    Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.
    Arch Bronconeumol. 2021;57:630-636.
    >> Share

  189. SUEHS CM, Bourdin A
    Tapering of Oral Corticosteroids for the Treatment of Asthma.
    Arch Bronconeumol. 2021;57:621-622.
    >> Share

  190. COHEN M, Casas A, Zabert G, Torres-Duque CA, et al
    Updated Strategic Plan of the Latin American Thoracic Association (ALAT). "The ten commandments for 2021-2026 quinquennial".
    Arch Bronconeumol. 2021;57:617-620.
    >> Share

  191. MARTINEZ-VERGARA A, Giron RM, Churruca-Arrospide M, Lopez-Pereira P, et al
    Clinical course of patients with bronchiolitis obliterans following hematopoietic stem cell transplantation.
    Arch Bronconeumol. 2021;57:664-666.
    >> Share

    September 2021
  192. ALCARAZ-SERRANO V, Lee AL, Gimeno-Santos E
    Respiratory Physiotherapy and Bronchiectasis.
    Arch Bronconeumol. 2021 Sep 14. pii: S0300-2896(21)00316.
    >> Share

  193. BLANCO-CONDE S, Gonzalez-Cortes C, Lopez-Medrano R, Carazo-Fernandez L, et al
    Mycobacterium abscessus Infected Neutrophils as an In Vitro Model for Bronchiectasis. Neutrophils Prevent Mycobacterial Aggregation.
    Arch Bronconeumol. 2021 Sep 4. pii: S0300-2896(21)00231.
    >> Share

  194. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
    Vitamin D supplementation: A treatment with possible benefits in asthma.
    Arch Bronconeumol. 2021;57:567-568.
    >> Share

  195. GOLPE R, Dacal-Rivas D, Blanco-Cid N, Castro-Anon O, et al
    Need for Epidemiological Studies on Chronic Obstructive Pulmonary Disease in Rural Spain.
    Arch Bronconeumol. 2021;57:614-615.
    >> Share

  196. CARRASCO HERNANDEZ L, Caballero Eraso C, Abad Arranz M, Marquez Martin E, et al
    Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow.
    Arch Bronconeumol. 2021;57:593-594.
    >> Share

  197. COSIO BG, Shafiek H, Verdu J, Fiorentino F, et al
    Implementation of an Integrated Care Model for Frequent-Exacerbator COPD Patients: A Controlled Prospective Study.
    Arch Bronconeumol. 2021;57:577-583.
    >> Share

  198. ALONSO-PEREZ T, Garcia-Castillo E, Lopez-Campos JL
    Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?
    Arch Bronconeumol. 2021;57:604-605.
    >> Share

  199. LOPEZ-CAMPOS JL, Calle Rubio M, Izquierdo Alonso JL, Fernandez-Villar A, et al
    Forum COPD working group consensus on the diagnosis, treatment and follow-up of COPD.
    Arch Bronconeumol. 2021;57:596-599.
    >> Share

    August 2021
  200. EZPONDA A, Casanova C, Cabrera C, Martin-Palmero A, et al
    Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients.
    Arch Bronconeumol. 2021;57:533-539.
    >> Share

  201. MOROLI RG, Santos DOD, Souza HCD, Perossi L, et al
    Effects of Controlled Voluntary Increase in the Ventilatory Demand on Respiratory System Resistance in Healthy and Non-Cystic Fibrosis Bronchiectasis Subjects: A Cross-Sectional Study.
    Arch Bronconeumol. 2021;57:528-532.
    >> Share

  202. GARCIA-SANZ MT, Gonzalez-Barcala FJ
    COPD is more than just lung function: Let's not forget depression.
    Arch Bronconeumol. 2021;57:519-520.
    >> Share

    July 2021
  203. MCDONALD VM, Gibson PG
    Treatable Traits in Asthma and COPD.
    Arch Bronconeumol. 2021 Jul 16. pii: S0300-2896(21)00206.
    >> Share

  204. LOPEZ-VILLARRUBIA E, Costa Estirado O, Iniguez Hernandez C, Ballester Diez F, et al
    Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?
    Arch Bronconeumol. 2021;57:464-470.
    >> Share

    June 2021
  205. MARCHIORI E, Souza Rodrigues R, Menna Barreto M
    Exuberant Paraseptal Emphysema Associated With Pulmonary Alveolar Microlithiasis: 12 Years of Evolution.
    Arch Bronconeumol. 2021 Jun 24. pii: S0300-2896(21)00196.
    >> Share

    April 2021
  206. SAWAMURA MVY, Athanazio RA, Nucci MCNTM, Rached SZ, et al
    Automated Computed Tomography Lung Densitometry in Bronchiectasis Patients.
    Arch Bronconeumol. 2021 Apr 25. pii: S0300-2896(21)00136.
    >> Share

    January 2021
  207. ALMONACID C, Blanco-Aparicio M, Dominguez-Ortega J, Giner J, et al
    [Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19].
    Arch Bronconeumol. 2021;57:13-14.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016